Hydrogels that kill bacteria to help heal bone fractures
Bactericidal hydrogels for bone repair
['FUNDING_R01'] · GEORGIA INSTITUTE OF TECHNOLOGY · NIH-11083622
This study is testing new gel-like materials that can deliver antibiotics and a special enzyme right to infected bone fractures to help heal them better and reduce the need for other medications, making it a promising option for people dealing with bone injuries and infections.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEORGIA INSTITUTE OF TECHNOLOGY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11083622 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative hydrogels that can deliver antibiotics and an enzyme called lysostaphin directly to infected bone fractures. By targeting bacterial infections at the site of injury, the goal is to improve healing outcomes and reduce the need for systemic antibiotics, which can have side effects. The research will be conducted using animal models to test the effectiveness of these hydrogels in eliminating infections and promoting bone repair. If successful, this approach could lead to better treatment options for patients with bone injuries complicated by infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with bone fractures or non-union defects that are at risk of bacterial infection.
Not a fit: Patients with bone injuries that are not infected or those who do not require surgical intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more effective treatment for bone fractures that are complicated by bacterial infections, potentially reducing recovery time and improving patient outcomes.
How similar studies have performed: Other research has shown promise in using localized delivery systems for antibiotics, suggesting that this approach could be effective, although the specific use of hydrogels in this context is relatively novel.
Where this research is happening
ATLANTA, UNITED STATES
- GEORGIA INSTITUTE OF TECHNOLOGY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GARCIA, ANDRES J — GEORGIA INSTITUTE OF TECHNOLOGY
- Study coordinator: GARCIA, ANDRES J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: bacteria infection